SCM Lifescience Co., Ltd.

KOSDAQ:A298060 Voorraadrapport

Marktkapitalisatie: ₩50.6b

SCM Lifescience Beheer

Beheer criteriumcontroles 0/4

Momenteel beschikken wij niet over voldoende informatie over de CEO.

Belangrijke informatie

Byeong-gwan Son

Algemeen directeur

n/a

Totale compensatie

Percentage CEO-salarisn/a
Dienstverband CEO10.3yrs
Eigendom CEOn/a
Management gemiddelde ambtstermijngeen gegevens
Gemiddelde ambtstermijn bestuurgeen gegevens

Recente managementupdates

Geen updates

Recent updates

SCM Lifescience (KOSDAQ:298060) Has Debt But No Earnings; Should You Worry?

Nov 01
SCM Lifescience (KOSDAQ:298060) Has Debt But No Earnings; Should You Worry?

Is SCM Lifescience (KOSDAQ:298060) Using Too Much Debt?

Jul 05
Is SCM Lifescience (KOSDAQ:298060) Using Too Much Debt?

Is SCM Lifescience (KOSDAQ:298060) Using Debt In A Risky Way?

Feb 29
Is SCM Lifescience (KOSDAQ:298060) Using Debt In A Risky Way?

CEO

Byeong-gwan Son

10.3yrs

Tenure

Byeong-gwan Son is CEO & Chairman of SCM Lifescience Co., Ltd. from July 02, 2014. Byeong-gwan Son has experience serving as Manager of Inha University Hospital Pediatrics Professor, Director of Inha Unive...